Literature DB >> 16896675

[Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker].

R von Wasielewski1, K Klöpper, H J Lück, H Kreipe.   

Abstract

The grading of invasive breast cancers according to Bloom and Richardson (Nottingham modification) provides one of the most important prognostic factors in addition to size and the status of the lymph nodes. Diagnostic reproducibility has been problematic in daily practice as the required criteria for selection and extent of the grading area are frequently not present in the punch biopsies.A total of 346 cases were retrospectively used to compare routine grading from surgical preparations with an equivalently small sample from punch biopsies. In addition, a modified grading of these small samples was developed with Ki-67 immunochemistry and the measurement of core size. In the case of modified grading, 1-3 points were given for Ki-67 and average maximum core diameter. Tubule development was evaluated with 1 or 2 points. A comparison for recurrence free survival and total survival showed significant prognostic differences between 3-5 points (low risk) and 6-8 points (high risk) in uni- and multivariate analyses. The evaluation criteria for Nottingham-Bloom-Richardson grading in a small tissue sample, such as that from a punch biopsy, can hardly be fulfilled. In our series, prognostic value was only found for nodal negative cases. After modification using objective parameters such as nuclear size measurement and Ki-67 proliferation index, a small tissue sample can prove to be of significant prognostic value for nodal negative as well as nodal positive cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896675     DOI: 10.1007/s00292-006-0855-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  24 in total

1.  Assessment of pathologic prognostic factors in breast core needle biopsies.

Authors:  S Sharifi; M K Peterson; J K Baum; S Raza; S J Schnitt
Journal:  Mod Pathol       Date:  1999-10       Impact factor: 7.842

2.  Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial.

Authors:  Reinhard von Wasielewski; Michael Mengel; Birgitt Wiese; Thomas Rüdiger; Hans Konrad Müller-Hermelink; Hans Kreipe
Journal:  Am J Clin Pathol       Date:  2002-11       Impact factor: 2.493

3.  Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy.

Authors:  Andreas Schneeweiss; Julia Katretchko; Hans-Peter Sinn; Kristina Unnebrink; Christian Rudlowski; Matthias Geberth; Frank Beldermann; Gunther Bastert; Hans-Joachim Strittmatter
Journal:  Anticancer Drugs       Date:  2004-02       Impact factor: 2.248

4.  Prognostic indicators in breast cancer--morphometric methods.

Authors:  J P Baak; P H Kurver; A J De Snoo-Niewlaat; S De Graef; B Makkink; M E Boon
Journal:  Histopathology       Date:  1982-05       Impact factor: 5.087

5.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

6.  Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.

Authors:  H F Frierson; R A Wolber; K W Berean; D W Franquemont; M J Gaffey; J C Boyd; D C Wilbur
Journal:  Am J Clin Pathol       Date:  1995-02       Impact factor: 2.493

7.  Histological grading of breast carcinomas: a study of interobserver agreement.

Authors:  P Robbins; S Pinder; N de Klerk; H Dawkins; J Harvey; G Sterrett; I Ellis; C Elston
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

8.  Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma.

Authors:  Gavin C Harris; Helen E Denley; Sarah E Pinder; Andrew H S Lee; Ian O Ellis; Christopher W Elston; Andrew Evans
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

9.  Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade.

Authors:  P Kronqvist; T Kuopio; Y Collan
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

10.  Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer.

Authors:  P Kronqvist; T Kuopio; P Jalava; Y Collan
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

View more
  6 in total

1.  [Determination of proliferation in breast cancer by immunohistochemical detection of Ki-67].

Authors:  M Christgen; W Winkens; H H Kreipe
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

Review 2.  [Histological grading of breast cancer].

Authors:  M Christgen; F Länger; H Kreipe
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

Review 3.  [Ki67: biological intertumor variance versus variance of assay].

Authors:  H Kreipe
Journal:  Pathologe       Date:  2018-12       Impact factor: 1.011

Review 4.  [Translational research and diagnostics for breast cancer].

Authors:  H H Kreipe
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 5.  [Beyond staging, typing and grading. New challenges in breast cancer pathology].

Authors:  H H Kreipe; P Ahrens; M Christgen; U Lehmann; F Länger
Journal:  Pathologe       Date:  2010-02       Impact factor: 1.011

6.  Netrin-1 promotes glioma growth by activating NF-κB via UNC5A.

Authors:  Jing-Ying Chen; Xiao-Xiao He; Chi Ma; Xin-Min Wu; Xi-Lin Wan; Zhen-Kai Xing; Qing-Qing Pei; Xian-Ping Dong; Dong-Xu Liu; Wen-Cheng Xiong; Xiao-Juan Zhu
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.